$885 Million is the total value of Rubric Capital Management LP's 48 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DD | New | DUPONT DE NEMOURS INC | $45,261,000 | – | 705,000 | +100.0% | 5.12% | – |
MO | New | ALTRIA GROUP INC | $44,669,000 | – | 895,000 | +100.0% | 5.05% | – |
AVYA | New | AVAYA HLDGS CORP | $37,744,000 | – | 2,795,818 | +100.0% | 4.27% | – |
CSTM | New | CONSTELLIUM SE | $23,173,000 | – | 1,729,310 | +100.0% | 2.62% | – |
TSN | New | TYSON FOODS INCcl a | $16,387,000 | – | 180,000 | +100.0% | 1.85% | – |
CHNG | New | CHANGE HEALTHCARE INC | $10,495,000 | – | 640,300 | +100.0% | 1.19% | – |
CCO | New | CLEAR CHANNEL OUTDOOR HLDGS | $9,081,000 | – | 3,175,132 | +100.0% | 1.03% | – |
IPHA | New | INNATE PHARMA S Asponsored ads | $8,694,000 | – | 1,350,000 | +100.0% | 0.98% | – |
BMYRT | New | BRISTOL MYERS SQUIBB COright 99/99/9999 | $7,869,000 | – | 2,614,417 | +100.0% | 0.89% | – |
SAIC | New | SCIENCE APPLICATNS INTL CP N | $4,958,000 | – | 56,973 | +100.0% | 0.56% | – |
ASRT | New | ASSERTIO THERAPEUTICS INC | $4,500,000 | – | 3,600,316 | +100.0% | 0.51% | – |
TBPH | New | THERAVANCE BIOPHARMA INC | $4,489,000 | – | 173,400 | +100.0% | 0.51% | – |
HIIQ | New | HEALTH INS INNOVATIONS INCcall | $3,858,000 | – | 200,000 | +100.0% | 0.44% | – |
VG | New | VONAGE HLDGS CORP | $2,596,000 | – | 350,371 | +100.0% | 0.29% | – |
EIDX | New | EIDOS THERAPEUTICS INC | $1,640,000 | – | 28,579 | +100.0% | 0.18% | – |
SRNE | New | SORRENTO THERAPEUTICS INC | $1,513,000 | – | 447,610 | +100.0% | 0.17% | – |
MDRIQ | New | MCDERMOTT INTL INCput | $582,000 | – | 860,300 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
AAR CORP | 14 | Q3 2023 | 3.2% |
GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-10 |
DFAN14A | 2024-05-08 |
DFAN14A | 2024-05-03 |
DFAN14A | 2024-05-01 |
DFAN14A | 2024-04-30 |
DFAN14A | 2024-04-29 |
DEFC14A | 2024-04-17 |
DFAN14A | 2024-04-17 |
SC 13D/A | 2024-04-16 |
PRRN14A | 2024-04-02 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.